MEDP: Medpace Holdings, Inc. - Summary | Jitta

Medpace Holdings, Inc.

NASDAQ:MEDP

Price
$417.02
Loss Chance
40.4%
7.61JITTA SCORE
17.73%Over Jitta Line
Jitta Ranking
39 / 717
432 / 4,223
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (75)
Recent Business Performance (73)
Financial Strength (83)
Return to Shareholders (63)
Competitive Advantage (84)
Jitta Signs
Revenue and EarningConsistent High Growth in the past 5 years
Recent Business PerformanceEarning Growth Last Year
Debt LevelLow Long Term Debt
Return on EquityConsistently High
Share RepurchaseEvery Year
CapExVery Low
SG&A to SalesDecreasing Every Year
Cash Conversion CycleLess than 60 days
Key Stats
Jitta Score
Jitta Line
7.61
17.73%
3.07
432.53%
Life Sciences Tools and Services
7.24
171.25%
6.03
51.63%
5.68
78.06%
COMPANY DESCRIPTION
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.